Tuesday, June 24, 2014

DCRA emergency rulemaking regarding synthetic drugs (like K2)

From: jmandel@DCCOUNCIL.US
Date: Tue, 24 Jun 2014 16:50:50 -0400
Subject: Questions on K-2/Synthetic Drugs

Hi Scott,

I received a number of inquiries on K-2 and synthetic narcotics at last week’s Bloomingdale Civic Association meeting. I contacted MPD and confirmed DCRA was working on a proposed rulemaking (attached), which was recently adopted on an emergency basis.  There are now enforcement penalties for businesses engaging in the sale, possession, or manufacturing of synthetic drugs, including the suspension or revocation of their business license.

Section 904, REVOCATION OF BUSINESS LICENSE, is amended to read as follows:


904.1     Any business licensee violating this chapter may receive a Notice of Infraction.

904.2     DCRA may issue a notice of intent to suspend or revoke the licensee’s basic business license for violating this chapter.

904.3     Following an adjudication that is adverse to the business licensee, DCRA shall suspend or revoke the basic business license.  In adjudicated cases where a notice of intent to revoke was issued, the basic business license shall be revoked pursuant to D.C. Official Code § 47-2844(a-1)(1), and the licensee shall be ineligible to apply for a new basic business license for a substantially similar business for two (2) years.
Thank you.

Jon Mandel
Legislative Aide
Office of Councilmember Kenyan R. McDuffie, Ward 5
Chairman Pro Tempore
Chair, Committee on Government Operations
1350 Pennsylvania Ave. NW, Suite G-11
Washington, DC 20004
Visit us on the web at www.kenyanmcduffie.com

No comments: